Alliance between Philips, Maastricht UMC+ and University Clinic Aachen

Royal Philips ElectronicsThe Maastricht University Medical Centre (UMC+), University Medical Center Aachen (UKA) and Royal Philips Electronics N.V. announced that they are to set up a strategic partnership, the aim of which is to pool their knowledge, expertise and experience in the field of healthcare. The planned cooperation will make it possible for new scientific findings to be made available more quickly for routine application in hospitals, thus benefiting patients. The universities of Aachen and Maastricht are also supporting the initiative.

Among others, Prof. Henning Saß and Guy Peeters MD, chairmen of the Boards of Management of the Aachen and Maastricht medical centers respectively, Dr. Henk van Houten, head of the Healthcare Research Program at Philips Research, and Jochen Franke, CEO Philips Healthcare DACH (Germany, Austria and Switzerland), signed a letter of intent at the 'Biomedica 2008' international Life Science Summit in Maastricht, the Netherlands. The signing took place in the presence of Mrs M. van der Hoeven and Mrs C. Thoben, Ministers of Economic Affairs for the Netherlands and the German federal state of North-Rhine Westphalia respectively, and Prof. Andreas Pinkwart, Minister for Research and Innovation in North-Rhine Westphalia.

Philips and the two university medical centers intend to work closely together and to combine their advanced clinical knowledge and research specifically in the fields of cardiovascular disease and cancer treatment. Their cooperation will cover the research, development and application of new diagnostic and treatment methods. Among other things, the partners' aim is to set up a joint research program in the field of medical imaging technology.

"Shortages in the labor market and increasing competition in the healthcare sector are making it increasingly important to set up international joint ventures to ensure that we can continue bringing about the necessary innovation. National boundaries should not be a barrier to this," says G. Peeters MD, chairman of the Board of Management of the Maastricht UMC+.

Prof. Henning Saß, chairman of the Board of Management of the University Clinic in Aachen comments, "This will benefit both the patient and the participating partners, because it will enable us all to strengthen our European and international competitive position."

Dr. Henk van Houten, Senior Vice President Philips Research, who is in charge of the healthcare research program at Philips Research, adds, "This alliance will give rise to advanced clinical care, as well as ground-breaking clinical research to find an integrated approach to diagnosis and therapy for cancer and cardiovascular disease. The opportunity to work together with highly reputable academic partners in order to link clinical research and healthcare to the application of new medical technologies represents a very exciting prospect for Philips."

Related news articles:

About Royal Philips Electronics
Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is a global leader in healthcare, lighting and consumer lifestyle, delivering people-centric, innovative products, services and solutions through the brand promise of "sense and simplicity". Headquartered in the Netherlands, Philips employs approximately 134,200 employees in more than 60 countries worldwide. With sales of EUR 27 billion in 2007, the company is a market leader in medical diagnostic imaging and patient monitoring systems, energy efficient lighting solutions, as well as lifestyle solutions for personal wellbeing. News from Philips is located at www.philips.com/newscenter.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...